A novel series of IKKβ inhibitors part II: Description of a potent and pharmacologically active series of analogs
作者:Timothy D. Cushing、Vijay Baichwal、Karen Berry、Roland Billedeau、Viola Bordunov、Chris Broka、Michelle F. Browner、Mario Cardozo、Peng Cheng、David Clark、Stacie Dalrymple、Michael DeGraffenreid、Adrian Gill、Xiaolin Hao、Ronald C. Hawley、Xiao He、Sharada S. Labadie、Marc Labelle、Csaba Lehel、Pu-Ping Lu、Joel McIntosh、Shichang Miao、Camran Parast、Youngsook Shin、Eric B. Sjogren、Marie-Louise Smith、Francisco X. Talamas、George Tonn、Keith M. Walker、Nigel P.C. Walker、Holger Wesche、Chris Whitehead、Matt Wright、Juan C. Jaen
DOI:10.1016/j.bmcl.2010.10.125
日期:2011.1
A novel series of (E)-1-((2-(1-methyl-1H-imidazol-5-yl) quinolin-4-yl) methylene) thiosemicarbazides was discovered as potent inhibitors of IKK beta. In this Letter we document our efforts at further optimization of this series, culminating in 2 with submicromolar potency in a HWB assay and efficacy in a CIA mouse model. (c) 2010 Elsevier Ltd. All rights reserved.